BBT vs NBTB

The Advanced Deterministic Scorecard reveals significant concerns with a weak Piotroski F-Score of 4/9, indicating marginal financial health, and a missing Altman Z-Score prevents a full distress risk assessment. Despite a seemingly attractive Price/Book of 0.98 and a high dividend yield of 4.40%, the company is plagued by negative operating margins (-35.62%), collapsing revenue growth (-32.20% YoY), and an unsustainably high payout ratio of 600%. While analysts maintain a 'buy' recommendation with a target price above current levels, deteriorating profitability, insider selling, and a bearish technical trend contradict this optimism. The stock trades at a massive premium to its Graham Number ($11.65) and intrinsic value ($1.47), suggesting severe overvaluation relative to fundamentals.

NBTB exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and significant valuation upside, trading well below its Graham Number ($52.17) and Intrinsic Value ($98.23). The company demonstrates exceptional growth momentum with 39.5% YoY earnings growth and a stellar 25-quarter track record of meeting or beating estimates. While technical trends are currently bearish (10/100) and insider activity is slightly negative, the fundamental value and growth trajectory strongly outweigh these short-term signals.